These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 20538051)

  • 21. Pharmacokinetics and pharmacodynamics of nifedipine in untreated and atorvastatin-treated hyperlipidemic rats.
    Eliot LA; Jamali F
    J Pharmacol Exp Ther; 1999 Oct; 291(1):188-93. PubMed ID: 10490903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study on acute antihypertensive effects and pharmacokinetics of nisoldipine, nifedipine, nimodipine and nicardipine administered orally to conscious renal hypertensive dogs.
    Takata Y; Kato H
    Arzneimittelforschung; 1986 Oct; 36(10):1464-71. PubMed ID: 3814208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral nifedipine pharmacokinetics in pregnancy-induced hypertension.
    Prevost RR; Akl SA; Whybrew WD; Sibai BM
    Pharmacotherapy; 1992; 12(3):174-7. PubMed ID: 1608848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of nifedipine-loaded coated gelatin microcapsule as a long acting oral delivery.
    Li DX; Kim JO; Oh DH; Lee WS; Hong MJ; Kang JY; Choi JS; Woo JS; Yong CS; Choi HG
    Arch Pharm Res; 2009 Jan; 32(1):127-32. PubMed ID: 19183885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and pharmacodynamics of two commercial oral nifedipine products.
    Shaheen O; Zmeili S; al-Qussuois Y; Arafat T; Mouti H
    Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):337-41. PubMed ID: 1937993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of small intestinal cytochromes p450 in the bioavailability of oral nifedipine.
    Zhang QY; Kaminsky LS; Dunbar D; Zhang J; Ding X
    Drug Metab Dispos; 2007 Sep; 35(9):1617-23. PubMed ID: 17567730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of once-daily theophylline dose following the morning versus evening administration.
    Trnavská Z; Vondra V; Elis J
    Arzneimittelforschung; 1989 Sep; 39(9):1149-51. PubMed ID: 2590267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraine.
    Haberer LJ; Walls CM; Lener SE; Taylor DR; McDonald SA
    Headache; 2010 Mar; 50(3):357-73. PubMed ID: 20132340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of an oral once-a-day controlled-release oxybutynin formulation compared with immediate-release oxybutynin.
    Gupta SK; Sathyan G
    J Clin Pharmacol; 1999 Mar; 39(3):289-96. PubMed ID: 10073329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Impact of the method and timing of administration on the systemic transport of ketoprofen].
    Delhotal Landes B; Decout N; Molinier P; Flouvat B
    Pathol Biol (Paris); 1998 May; 46(5):355-9. PubMed ID: 9769898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronopharmacokinetics and cardiovascular effects of nifedipine.
    Lemmer B; Nold G; Behne S; Kaiser R
    Chronobiol Int; 1991; 8(6):485-94. PubMed ID: 1799930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on interactions between functional foods or dietary supplements and medicines. III. Effects of ginkgo biloba leaf extract on the pharmacokinetics of nifedipine in rats.
    Yoshioka M; Ohnishi N; Sone N; Egami S; Takara K; Yokoyama T; Kuroda K
    Biol Pharm Bull; 2004 Dec; 27(12):2042-5. PubMed ID: 15577230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Da-Chaihu-Tang alters the pharmacokinetics of nifedipine in rats and a treatment regimen to avoid this.
    He JX; Ohno K; Tang J; Hattori M; Tani T; Akao T
    J Pharm Pharmacol; 2014 Nov; 66(11):1623-30. PubMed ID: 24961584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extrahepatic first-pass metabolism of nifedipine in the rat.
    Grundy JS; Eliot LA; Foster RT
    Biopharm Drug Dispos; 1997 Aug; 18(6):509-22. PubMed ID: 9267683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of oral nifedipine in different populations.
    Castañeda-Hernández G; Hoyo-Vadillo C; Palma-Aguirre JA; Flores-Murrieta FJ
    J Clin Pharmacol; 1993 Feb; 33(2):140-5. PubMed ID: 8440762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple-dose pharmacokinetics of nilvadipine in healthy volunteers.
    Terakawa M; Tokuma Y; Kuwahara N; Shishido A; Noguchi H
    J Clin Pharmacol; 1988 Apr; 28(4):350-5. PubMed ID: 3392233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of nifedipine after oral administration in chronic liver disease.
    Ene MD; Roberts CJ
    J Clin Pharmacol; 1987 Dec; 27(12):1001-4. PubMed ID: 3437063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moment analysis of intravenous, intraduodenal, buccal, rectal and percutaneous nifedipine in rats.
    Kondo S; Sugimoto I
    J Pharmacobiodyn; 1987 Sep; 10(9):462-9. PubMed ID: 3437389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of posture on the pharmacokinetics of orally administered nifedipine.
    Renwick AG; Ahsan CH; Challenor VF; Daniels R; Macklin BS; Waller DG; George CF
    Br J Clin Pharmacol; 1992 Oct; 34(4):332-6. PubMed ID: 1457267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sublingual nifedipine: the continuing controversy.
    Oliver S
    Aust Crit Care; 1994 Jun; 7(2):12-4. PubMed ID: 8061479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.